|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-4-1
|
|
pubmed:abstractText |
Infants represent a very poor risk group for acute lymphoblastic leukemia (ALL). We report treatment outcome for such patients treated with intensive therapy on consecutive Children's Cancer Group (CCG) protocols.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:FeusnerJ HJH,
pubmed-author:GaynonP SPS,
pubmed-author:HeeremaN ANA,
pubmed-author:HolmesE JEJ,
pubmed-author:JohnstoneH SHS,
pubmed-author:LangeB JBJ,
pubmed-author:LeonardMM,
pubmed-author:O'BrienR TRT,
pubmed-author:PendergrassT WTW,
pubmed-author:ReamanG HGH,
pubmed-author:SatherH NHN,
pubmed-author:SenselM GMG,
pubmed-author:SpostoRR,
pubmed-author:SteinherzP GPG,
pubmed-author:TriggM EME,
pubmed-author:UckunF MFM,
pubmed-author:ZeltzerP MPM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
445-55
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10080584-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10080584-Bone Marrow Transplantation,
pubmed-meshheading:10080584-Combined Modality Therapy,
pubmed-meshheading:10080584-Female,
pubmed-meshheading:10080584-Humans,
pubmed-meshheading:10080584-Infant,
pubmed-meshheading:10080584-Male,
pubmed-meshheading:10080584-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10080584-Prognosis,
pubmed-meshheading:10080584-Risk Factors,
pubmed-meshheading:10080584-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
|
|
pubmed:affiliation |
Children's National Medical Center and George Washington University School of Medicine, Washington, DC, USA. greaman@cnmc.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|
